首页 | 本学科首页   官方微博 | 高级检索  
     


Subgroup analysis of virological response rates with once‐ and twice‐daily darunavir/ritonavir in treatment‐experienced patients without darunavir resistance‐associated mutations in the ODIN trial
Authors:M Sension  P Cahn  P Domingo  S Hodder  M Opsomer  E Lathouwers  T Van de Casteele  F Tomaka
Affiliation:1. Comprehensive Care Center, , Fort Lauderdale, FL, USA;2. Huésped Foundation, , Buenos Aires, Argentina;3. Autonomous University of Barcelona, , Barcelona, Spain;4. University of Medicine and Dentistry of New Jersey, , Newark, NJ, USA;5. Janssen Infectious Diseases BVBA, , Beerse, Belgium;6. Janssen Research & Development, LLC, , Titusville, NJ, USA
Abstract:
Keywords:darunavir  efficacy  HIV  once daily  treatment‐experienced
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号